SOD1 and amyotrophic lateral sclerosis: While MCC950 treatment inhibited cytosolic Fla-BS-induced IL-1β release by 50-60% across iMGL lines (Figures S2E, F), PI uptake was not decreased by MCC950 in both healthy control and SOD1 ALS lines (Figures S2G, H).